TiGenix announces acceptance of Cx601 abstract for presentation at ECCO 2016 Congress
LEUVEN, Belgium, Jan. 11, 2016 (GLOBE NEWSWIRE) -- TiGenix NV (Euronext Brussels: TIG), an advanced biopharmaceutical company focused on developing and commercialising novel therapeutics from its proprietary platforms of allogeneic expanded stem cells, …